
Karuna Therapeutics KRTX
Quarterly report 2023-Q3
added 05-16-2026
Karuna Therapeutics P/E Ratio 2011-2026 | KRTX
Annual P/E Ratio Karuna Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -27.2 | -22 | -21.3 | -48.2 | -23.7 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -21.3 | -48.2 | -28.5 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arcturus Therapeutics Holdings
ARCT
|
-3.3 | $ 7.15 | 1.64 % | $ 196 M | ||
|
FSD Pharma
HUGE
|
-2.15 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.183 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
5.53 | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
1.35 | $ 1.69 | 4.66 % | $ 198 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
BioNTech SE
BNTX
|
-19.4 | $ 92.82 | 0.74 % | $ 22.4 B | ||
|
AstraZeneca PLC
AZN
|
16.3 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-0.0167 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-18.5 | - | 0.74 % | $ 768 M | ||
|
Compugen Ltd.
CGEN
|
5.55 | $ 2.72 | -2.86 % | $ 254 M | ||
|
Abcam plc
ABCM
|
-581 | - | - | $ 4.9 B | ||
|
Galera Therapeutics
GRTX
|
-0.403 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-251 | - | -18.52 % | $ 27.3 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
0.0355 | $ 0.67 | -6.24 % | $ 30.6 M | ||
|
Esperion Therapeutics
ESPR
|
-24.7 | $ 3.13 | -0.16 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
-121 | $ 31.47 | -3.44 % | $ 847 M | ||
|
Affimed N.V.
AFMD
|
-9.16 | - | -34.95 % | $ 21.5 M | ||
|
Forte Biosciences
FBRX
|
-4.83 | $ 21.98 | 1.81 % | $ 285 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.859 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-0.259 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-1.19 | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
-1.41 | - | - | $ 344 M | ||
|
IMV
IMV
|
-0.18 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-2.12 | - | 0.23 % | $ 488 M | ||
|
Grifols, S.A.
GRFS
|
21.2 | $ 8.03 | 0.56 % | $ 5.46 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Heron Therapeutics
HRTX
|
-9.92 | $ 0.87 | 1.11 % | $ 145 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
0.00975 | - | -4.36 % | $ 27 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-2.93 | - | - | $ 384 M | ||
|
Gracell Biotechnologies
GRCL
|
-4.4 | - | - | $ 3.37 B | ||
|
Anika Therapeutics
ANIK
|
-19.7 | $ 14.63 | -1.68 % | $ 210 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
InflaRx N.V.
IFRX
|
-1.39 | $ 2.76 | 5.75 % | $ 186 M | ||
|
Aeterna Zentaris
AEZS
|
-0.964 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.735 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.489 | $ 3.49 | 2.65 % | $ 5.75 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
-16.1 | - | -0.23 % | $ 916 M |